By Joseph Burns, from the Volume XXIV, No. 3 – February 21, 2017 issue
CEO SUMMARY: There’s great news for pathologists and PhDs with expertise in molecular and genetic testing. Salaries are on the rise as more clinical labs build up their molecular and genetic testing programs and need talent to implement and supervise this activity. One experienced medical recruiter recently surveyed all the current pathology openings nationally. He
By Joseph Burns, from the Volume XIX No. 14 - October 8, 2012 issue
CEO SUMMARY: There will be an expanding role for innovative clinical labs as healthcare moves forward on its path toward personalized medicine. However, to capitalize on this opportunity, pathology groups and clinical labs will need to beef up their information systems. They will also need to recruit lab staff who are skilled in interpreting molecular
By Robert Michel, from the Volume XV No. 16 - December 01, 2008 issue
CEO Summary: At the upcoming Molecular Summit in Philadelphia on February 10-11, 2009, pathologists, molecular imaging experts, and informaticians will share the latest developments on the integration of in vivo (imaging) and in vitro (pathology) diagnostics. A major theme will be discussion about multi-modality diagnostics and how this new discipline—driven by advances in genetics and
By R. Lewis Dark, from the Volume XV No. 16 - December 01, 2008 issue
DO RADIOLOGISTS AND PATHOLOGISTS have a common future in the age of personalized medicine? That’s not an idle question as new technologies help both medical specialties to better understand how molecular processes play a role in various diseases.
Oncology may prove to be the powerful force that encourages collaboration and greater clinical integration between radiology and
By Robert Michel, from the Volume XIV No. 6 - April 23, 2007 issue
CEO SUMMARY: As genomic medicine advances, researchers into various diseases quickly recognize the need to incorporate molecular pathologists onto their teams. In Grand Rapids, Michigan, a large integrated health system and a private research institute have come together to jointly fund a state-of-the-art molecular pathology laboratory. The twin goals are to advance research and create
By Robert Michel, from the Volume XIV No. 3 - February 19, 2007 issue
CEO SUMMARY: Doctors rely on labs for the definitive diagnosis of the bacterium that causes whooping cough. Yet in several recent cases, the use of a molecular test for a definitive diagnosis led to questions about the effectiveness of the test. Molecular pathologists recommend labs may need to do a second test to confirm initial
